Atrial fibrillation (AF) is the most frequent cardiac arrhythmia increasing the risk of stroke and mortality from heart failure. Magnetic resonance imaging was used by several authors for assessment of atrial fibrosis and to predict the rate of recurrence following AF ablation. The aim of this manuscript was to summarize the new data in the literature regarding the role of atrial fibrosis in AF imaging and the role of cardiac fibrosis in predicting AF recurrence after radiofrequency ablation.
INTRODUCTION
Atrial fibrillation (AF) is the most common cardiac arrhythmia, with a prevalence of 0.4-1% in the general population. AF increases the risk of stroke, approximately 15% of all strokes being caused by AF. AF also significantly increases the risk of mortality from heart failure. 1 Rhythm control therapy, including pharmacological therapy and direct electrical cardioversion, was not found to be as effective as catheter ablation in maintaining sinus rhythm and symptom management. 2, 3 Catheter ablation of AF consisting especially in pulmonary vein (PV) isolation (with electro-anatomic mapping) has provided better outcomes when applied in patients with paroxysmal AF. 4, 5 However, the long-term efficacy, despite significant technological improvements, remains controversial.
The degree of atrial fibrosis influences the outcome of pulmonary vein isolation performed by various ablation techniques (cryo or radiofrequency). There are several methods for the evaluation of left atrial anatomy, pulmonary veins or left appendage, but only late gadolinium-enhanced cardiac magnetic resonance (LGE-CMR) can evaluate the degree of atrial fibrosis. To predict the outcome of AF ablation, several parameters should be analyzed: the type of atrial fibrillation (paroxysmal, persistent, long-standing persistent), the coronary status and anatomy, associated pathologies, the type of ablation (cryo, radiofrequency), the le-sion formation (contact force catheter), and the ablation site (only pulmonary vein isolation, other ablation lines). It is also important to define AF recurrence and what methods are used to demonstrate complete isolation of the pulmonary veins: Holter monitoring, loop recorder, electrophysiological study for complete vein isolation. There are no available large studies in the literature demonstrating strong correlations between various parameters and long-term success rate. Later studies, especially after MRI was introduced as an evaluation method for atrial function, found significant correlations between the degree of atrial fibrosis and long-term outcome after AF ablation, and showed the role of electroanatomic guided pulmonary vein isolation. 6,7 FIGURE 1. 3D anatomo-electrical mapping used during the complex navigation procedures for AF ablation in the catheterization laboratory. A, B -isolation of pulmonary veins; C -intracardiac ECG tracing during an EP study for AF ablation
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CAThETER AbLATION IN AF
Catheter ablation of AF has continuously improved as a treatment option (both in procedure time and safety terms) in the last ten years. Figure 1 presents an exemplification of the 3D anatomo-electrical mapping used during the complex navigation procedures for catheter AF ablation in the catheterization laboratory.
Despite the significant progress encountered in recent years in ablation techniques, the success rate is currently ranging between 50% and 70%. 8, 9 Recent developments in ablation techniques did not lead to an increase in the procedure's success rate. In many patients, only repeated procedures can suppress the arrhytmia. 10 A prospective multicenter study that included 167 patients with paroxysmal atrial fibrillation, comparing PVI with antiarrhythmic medication, showed that 66% of subjects had better results following ablation during the 9 months of follow-up, compared to patients that had received antiarrhythmic drugs. 11 Currently the most challenging task is to parallelly improve ablation techniques, as well as to find new arrhythmia substrates and to reduce the recurrence rates of atrial fibrillation. Fibrotic atrial regions are thought to contribute not only to the initiation, but also to the maintenance of AF. The best imaging method to evaluate left atrial fibrosis is magnetic resonance imaging, and late gadoliniumenhancement MRI is able to quantify the degree of atrial fibrosis, which is linked to the degree of left atrium (LA) remodeling, as well as to the rates of recurrence of atrial fibrillation following the ablation.
It has been shown that arrhythmia recurrence is significantly higher when ≥30% fibrosis is present on preprocedural MRI scans, while fibrosis <30% shows better results after catheter ablation procedures. Noninvasive evaluation of the myocardial tissue using LGE-MRI is a powerful tool for finding and quantifying atrial tissue changes resulting from the fibrosis. The extent of LA fibrosis is positively correlated with the amount of time the patients had been in atrial fibrillation, and persistent AF was linked with a more increased LA volume and fibrosis. 12 Nowadays, the selection of candidates for catheter ablation remains subjective, usually including patients with failed antiarrhythmic drug therapy. We can improve ablation outcomes with better and more objective selection criteria of patients with AF who undergo this procedure.
Bisbal et al., in a study on 102 patients with atrial fibrillation, observed that PVI led to a spherical reverse left atrial remodeling in 42.2% of patients and a reduction in LA volume in 69% of patients following the procedure. However, LA reverse spherical remodeling is suggested to be a sensitive marker of favorable remodeling after PV isolation compared to volumetric remodeling. 13 CMR image acquisition, image post-processing and procedural technique is very important when using LGE-MRI to identify gaps within the lines of ablation. This has raised controversies in the literature regarding the usefulness of LGE-MRI. Harrison et al. reported the inefficacy of LGE-CMR to provide information about electrical conduction following pulmonary vein isolation. The density of ablation points is significant when the electro-anatomical maps are recreated with the help of MRI, and gap re-isolation during repeated procedures leads to a significant decrease in the rate of AF recurrence. 14, 15 
INTEgRATION OF CMR INTO ThE ELECTROPhysIOLOgICAL LAbORATORy
Integrating CMR into the electrophysiology (EP) laboratory has recently been accepted and is expected to lead to important improvements in increasing the efficacy of PVI, with no conditions of exposure to radiation of neither the patient nor the operator. The possibility to provide reconstruction of complex navigation scar and fibrosis assessment, visualization of catheter placement and the ability to monitor the efficiency of radiofrequency ablation makes the on-site MRI very attractive. Initial experiences suggest that the method is feasible and safe. 16, 17 Radiation exposure has been significantly reduced with the new electroanatomic mapping equipment (NAVX, Carto). However, the use of interventional MRI would fully eliminate exposure to radiation. Identifying the areas with incomplete isolation detection of gaps during the procedure can lead to a better long-term outcome following AF ablation. Temporary limitations are represented by the compatible apparatus (electrocardiograph, catheters and ablation equipment) and a signal filter for better interpretation, and also a guaranteed patient safety (current defibrillators are not safe to be used inside the MRI equipment).
CONCLUsIONs
In conclusion, the analysis of left atrial wall fibrosis using MRI can lead to an appropriate patient selection for pulmonary vein isolation in atrial fibrillation. The post-abla-tion assessment of lesion formation and gap identification, as well as intraprocedural magnetic resonance imaging can improve the long-term outcome after ablation and can reduce the recurrence rates of AF.
